Back to search
FDAFDA · Food and drugs·Recall number D-804-2013

Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.

Published July 24, 2013 · Recall initiated: June 24, 2013

Summary

FDA records drug Class II recall D-804-2013, published July 24, 2013 and initiated June 24, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 221,600 vials; Lot: Lot #: 6003648, Exp. 6/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug; 15-month stability test station

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 6003648, Exp. 6/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01. recalled?

Yes. FDA published recall D-804-2013 on July 24, 2013. Reported hazard: Subpotent Drug; 15-month stability test station

What should I do if I have this product?

Voluntary: Firm initiated · Letter